Antioxidant Therapy in Nonalcoholic Steatohepatitis
Joint Authors
Deschenes, Marc
Ghali, Peter
al-Busafi, Said A.
Wong, Philip
Bhat, Mamatha
Source
Hepatitis Research and Treatment
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-11-22
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Nonalcoholic steatohepatitis (NASH) affects up to 3% of the North American population.
It occurs as a manifestation of the insulin-resistant state and oxidative stress is thought to be a key component of its pathophysiology.
Exercise and diet, which are the mainstay of therapy, are difficult to achieve and maintain with a disappointing long-term compliance record.
There is growing literature on the potential for antioxidant therapy.
The recent literature strongly suggests that vitamin E supplementation and other putative free radical scavengers and/or antioxidants are beneficial in improving biochemical and histological parameters in NASH.
American Psychological Association (APA)
al-Busafi, Said A.& Bhat, Mamatha& Wong, Philip& Ghali, Peter& Deschenes, Marc. 2012. Antioxidant Therapy in Nonalcoholic Steatohepatitis. Hepatitis Research and Treatment،Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-510492
Modern Language Association (MLA)
al-Busafi, Said A.…[et al.]. Antioxidant Therapy in Nonalcoholic Steatohepatitis. Hepatitis Research and Treatment No. 2012 (2012), pp.1-8.
https://search.emarefa.net/detail/BIM-510492
American Medical Association (AMA)
al-Busafi, Said A.& Bhat, Mamatha& Wong, Philip& Ghali, Peter& Deschenes, Marc. Antioxidant Therapy in Nonalcoholic Steatohepatitis. Hepatitis Research and Treatment. 2012. Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-510492
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-510492